首页> 外文OA文献 >FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia

【2h】

FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia

机译：国旗化疗随后使用非胶合性调节的同种异体干细胞移植诱导骨髓细胞骨髓纤维化的回归

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
M L Tanner; C K Hoh; A Bashey; P Holman; C Sun; H E Broome; T Lane; E D Ball; E Carrier;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia. [J] . Tanner ML, Hoh CK, Bashey A, Bone marrow transplantation . 2003,第6期

机译：FLAG化疗，然后使用非清髓性调理进行同种异体干细胞移植，可导致骨髓纤维化伴有髓样化生。
2. Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation. [J] . Steckel NK, Koldehoff M, Ditschkowski M, Transplantation: Official Journal of the Transplantation Society . 2007,第11期

机译：酪氨酸激酶（VAL617Phe）JAK2激活基因突变作为异基因干细胞移植后骨髓纤维化和髓样化生患者的最小残留疾病标志物的用途。
3. Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis [J] . Nicolaus Kr?ger, Michael Kvasnicka, Jürgen Thiele Fibrogenesis & Tissue Repair . 2012,第S1期

机译：同种异体干细胞移植替代骨髓纤维化患者的造血系统可导致骨髓纤维化的快速消退
4. Intravenous Busulfan Reduces Toxicity Associated with Myeloablative Allogeneic Hematopoietic Transplantation in Patients with Myeloid Malignancies [C] . A. Shimoni, B. Bxelorai, I. Hardan, European Haematology Association . 2002

机译：静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis [O] . Nicolaus Kröger, Michael Kvasnicka, Jürgen Thiele 2012

机译：同种异体干细胞移植替代骨髓纤维化患者的造血系统引起骨髓纤维化的快速消退
7. 4: Risk Factors for Allogeneic Stem Cell Transplantation in Patients With Myelofibrosis With Myeloid Metaplasia [O] . Baurmann H., Collenbusch F., Schmid C., 2008

机译：4：骨髓纤维化伴化生的患者异体干细胞移植的危险因素

FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia

著录项

引文网络

相似文献

相关主题

期刊订阅